Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

During the Trading Day
11.86 -0.02 / -0.17%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.86 +0.0024 / +0.02%
Volume: 1.2K
Health Technology

Company Description

Celldex Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. Its lead drug candidates include rindopepimut, glembatumumab vedotin and varlilumab. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Contact Information

Celldex Therapeutics, Inc.
Perryville III Building
Hampton New Jersey 08827
P:(908) 200-7500
Investor Relations:



Mutual fund holders63.02%
Other institutional26.53%
Individual stakeholders0.64%

Top Executives

Anthony S. MarucciPresident, Chief Executive Officer & Director
Avery W. CatlinCFO, Secretary, Treasurer & Senior Vice President
Tibor KelerChief Scientific Officer & Executive VP
Thomas Andrew DavisChief Medical Officer & Executive Vice President
Ronald A. PepinChief Business Officer & Senior Vice President